Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence

Enrolling by invitationOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

September 14, 2022

Primary Completion Date

May 30, 2025

Study Completion Date

December 31, 2026

Conditions
Cryptogenic Stroke
Trial Locations (1)

08013

Cooper Health System, Camden

All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

Covenant Health, Canada

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

Medical University of South Carolina

OTHER

collaborator

University of Maryland, Baltimore

OTHER

collaborator

University of Pennsylvania

OTHER

collaborator

Emory University

OTHER

collaborator

University of Chicago

OTHER

collaborator

University of Tennessee

OTHER

collaborator

Ohio State University

OTHER

collaborator

West Virginia University

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

Boston Medical Center

OTHER

collaborator

Rhode Island Hospital

OTHER

collaborator

Beth Israel Lahey Health

UNKNOWN

collaborator

Christiana Care Health Services

OTHER

collaborator

Henry Ford Health System

OTHER

collaborator

Thomas Jefferson University

OTHER

collaborator

University of Iowa

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

Allina Health System

OTHER

collaborator

Yale University

OTHER

collaborator

The University of Texas Health Science Center, Houston

OTHER

collaborator

Dartmouth-Hitchcock Medical Center

OTHER

collaborator

Virginia Commonwealth University

OTHER

lead

The Cooper Health System

OTHER